Drug profile · INN
antithrombin alfa
ATRYN
antithrombin alfa (ATRYN) is a coagulation factor x inhibitor.
EMA: withdrawn Blood and blood forming organs (B01) B01AB02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — antithrombin alfa
- Class
- Blood and blood forming organs (B01)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
antithrombin alfa (ATRYN) is a coagulation factor x inhibitor.
Key facts
INN antithrombin alfa
Brand ATRYN
Mechanism Coagulation factor X inhibitor
Target Coagulation factor X
Therapeutic class Blood and blood forming organs (B01)
ATC code B01AB02
Mechanism of action
Coagulation factor X inhibitor
Primary target: Coagulation factor X
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is antithrombin alfa?
antithrombin alfa (ATRYN) is a coagulation factor x inhibitor.
What is the brand name for antithrombin alfa?
ATRYN is a marketed brand name for antithrombin alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.